EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Neonatal acute kidney injury: diagnosis, recognition, and prevention

Thomas A Forbes, Naganandini Nagasundaram, Michelle C Starr, Matthew W Harer, Rute Baeta Baptista, Shina Menon, David T Selewski

Kidney International · 2026-08 · 110 (2) · 306-317

DOI: 10.1016/j.kint.2026.02.043 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Kidney International, 2026-08. Verfasst von Thomas A Forbes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Department of Nephrology, Royal Children's Hospital, Melbourne, Victoria, Aust…. Hauptthemen laut MEDLINE: Acute Kidney Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gerber Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute kidney injury (AKI) occurs in approximately one-third of babies treated in a neonatal intensive care unit. The establishment of consensus standardized definitions has improved clinical recognition and research into neonatal AKI. Neonatal AKI is now recognized for its independent associations with increased morbidity and neonatal intensive care unit mortality. Current definitions use increasing serum creatinine and/or decreasing urine output to diagnose AKI; however, these biomarkers reflect organ dysfunction long after injury has begun. Furthermore, they are impractical and insensitive metrics of kidney function in neonates, particularly in preterm neonates or the first weeks of life, when the risk is greatest. Given the lack of symptoms and limitations of current criteria, risk recognition and stratification are imperative to focus AKI stewardship. Urinary biomarkers (such as neutrophil gelatinase-associated lipocalin), which have demonstrated some challenges in adult studies, appear more promising in their capacity to reliably detect early pediatric and neonatal AKI. Even without novel biomarkers, numerous multidisciplinary AKI education and stewardship programs have demonstrated capacity to substantially reduce risk and incidence of AKI, particularly those focusing on the risk represented by nephrotoxic medication exposure. This narrative review reflects on the evolution of neonatal AKI definitions and how the improved epidemiologic understanding of the condition has been leveraged to drive quality improvement initiatives, development of risk stratification tools, improved diagnostics, and potential preventative therapies. Future integration of this burgeoning body of collaborative research will expedite accurate neonatal AKI diagnosis, while scaffolding kidney health surveillance into follow-up for the improvement of short- and long-term outcomes for these most vulnerable patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryHumansInfant, NewbornBiomarkersRisk FactorsLipocalin-2Risk AssessmentCreatininePredictive Value of TestsIntensive Care Units, Neonatal

Stichwörter der Autor:innen

acute kidney injuryneonatal acute kidney injuryneonatepediatric nephrology

Substanzen

BiomarkersLipocalin-2CreatinineLCN2 protein, human

Autor:innen und Institutionen

  • Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Department of Nephrology, Royal Children's Hospital, Melbourne, Victoria, Australia; Department of Paediatrics, University of Melbourne, Melbourne,…
  • Department of Nephrology, Royal Children's Hospital, Melbourne, Victoria, Australia; Department of General Paediatrics, Monash Children's Hospital, Melbourne, Victoria, Australia.
  • Division of Pediatric Nephrology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA; Division of Child Health Service Research, Department of Pediatrics, Indiana University Scho…
  • Division of Neonatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal; Pediatric Nephrology Unit, Department of Pediatrics, Hospital Dona Estefânia, Unidade Local de Saúde São José, Lisbon, Portugal.
  • Division of Nephrology, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California, USA.

Förderung

  • Gerber Foundation

Zitieren

APA

Forbes, T. A., Nagasundaram, N., Starr, M. C., Harer, M. W., Baptista, R. B., Menon, S., & Selewski, D. T. (2026). Neonatal acute kidney injury: diagnosis, recognition, and prevention. Kidney International, 110(2), 306-317. https://doi.org/10.1016/j.kint.2026.02.043

Vancouver

Forbes TA, Nagasundaram N, Starr MC, Harer MW, Baptista RB, Menon S, et al. Neonatal acute kidney injury: diagnosis, recognition, and prevention. Kidney International. 2026;110(2):306-317. doi:10.1016/j.kint.2026.02.043

BibTeX
@article{Forbes2026,
  author = {Forbes, Thomas A and Nagasundaram, Naganandini and Starr, Michelle C and Harer, Matthew W and Baptista, Rute Baeta and Menon, Shina and Selewski, David T},
  title = {Neonatal acute kidney injury: diagnosis, recognition, and prevention},
  journal = {Kidney International},
  year = {2026},
  volume = {110},
  number = {2},
  pages = {306--317},
  doi = {10.1016/j.kint.2026.02.043}
}
Kostenlos starten →